Notice of Intent To Prepare an Environmental Impact Statement, Public Scoping Meeting, and Request for Comments; Acquisition of Site for Development as a New Consolidated Campus for the Centers for Disease Control and Prevention/National Institute for Occupational Safety and Health (CDC/NIOSH) in Cincinnati, Ohio, 32553-32554 [2017-14474]
Download as PDF
<![CDATA[
Federal Register / Vol. 82, No. 134 / Friday, July 14, 2017 / Notices
32553
ESTIMATED ANNUALIZED BURDEN HOURS—Continued
Form name
Number of
respondents
Number of
responses per
respondent
Average
burden per
response
(in hours)
...........................................................
........................
........................
........................
Type of respondents
Total ...........................................
Leroy A. Richardson,
Chief, Information Collection Review Office,
Office of Scientific Integrity, Office of the
Associate Director for Science, Office of the
Director, Centers for Disease Control and
Prevention.
[FR Doc. 2017–14791 Filed 7–13–17; 8:45 am]
BILLING CODE 4163–18–P
Regulations (40 CFR parts 1500–1508).
CDC, in cooperation with GSA, also
intends to initiate consultation, as
required by Section 106 of the National
Historic Preservation Act (NHPA), to
evaluate the potential effects, if any, of
the Proposed Action on historic
properties.
DATES:
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Disease Control and
Prevention
[Docket No. CDC–2017–0059]
Notice of Intent To Prepare an
Environmental Impact Statement,
Public Scoping Meeting, and Request
for Comments; Acquisition of Site for
Development as a New Consolidated
Campus for the Centers for Disease
Control and Prevention/National
Institute for Occupational Safety and
Health (CDC/NIOSH) in Cincinnati,
Ohio
Centers for Disease Control and
Prevention (CDC), Department of Health
and Human Services (HHS).
ACTION: Notice of intent; announcement
of public meeting; and request for
comments.
AGENCY:
The Centers for Disease
Control and Prevention (CDC) within
the Department of Health and Human
Services (HHS), in cooperation with the
General Services Administration (GSA),
announces its intent to prepare an
Environmental Impact Statement (EIS)
to analyze and assess the environmental
impacts of the proposed acquisition of
a site in Cincinnati, Ohio, and the
development of this site into a new
consolidated CDC/National Institute for
Occupational Safety and Health
(NIOSH) campus (Proposed Action).
The site being considered for
acquisition and development is
bounded by Martin Luther King Drive
East to the south, Harvey Avenue to the
west, Ridgeway Avenue to the north,
and Reading Road to the east.
This notice is pursuant to the
requirements of the National
Environmental Policy Act of 1969
(NEPA) as implemented by the Council
on Environmental Quality (CEQ)
mstockstill on DSK30JT082PROD with NOTICES
SUMMARY:
VerDate Sep<11>2014
17:44 Jul 13, 2017
Jkt 241001
Public Scoping Meeting: A public
scoping meeting in open house format
will be held on August 1, 2017, in
Cincinnati, Ohio. The meeting will
begin at 6:00 p.m. and end no later than
9:00 p.m.
Written comments: Written scoping
comments must be submitted by August
14, 2017.
Deadline for Requests for Special
Accommodations: Persons wishing to
participate in the public scoping
meeting who need special
accommodations should contact Harry
Marsh at 770–488–8170 by 5:00 p.m.
Eastern Time, July 26, 2017.
ADDRESSES: The public scoping meeting
will be held at the Walnut Hills High
School, 3250 Victory Parkway,
Cincinnati, Ohio 45207. Attendees
should use the Parking Lot D entrance.
You may submit comments identified
by Docket No. CDC–2017–0059 by either
of the following methods:
• Federal eRulemaking Portal: https://
www.regulations.gov (Follow the
instructions for submitting comments).
• U.S. Mail: Harry Marsh, Architect,
Office of Safety, Security and Asset
Management (OSSAM), Centers for
Disease Control and Prevention, 1600
Clifton Road NE., MS–K80, Atlanta,
Georgia 30329–4027.
Instructions: All submissions must
include the agency name and Docket
Number. All relevant comments
received will be posted to https://
www.regulations.gov (personally
identifiable information, except for first
and last names, will be redacted). For
access to the docket to review
background documents or comments
received, go to https://
www.regulations.gov.
FOR FURTHER INFORMATION CONTACT:
Harry Marsh, Architect, Office of Safety,
Security and Asset Management
(OSSAM), Centers for Disease Control
and Prevention, 1600 Clifton Road NE.,
PO 00000
Frm 00026
Fmt 4703
Sfmt 4703
Total burden
(in hours)
200
MS–K80, Atlanta, Georgia 30329–4027,
phone: (770) 488–8170, or email: cdccincinnati-eis@cdc.gov.
SUPPLEMENTARY INFORMATION:
Background: CDC is dedicated to
protecting health and promoting quality
of life through the prevention and
control of disease, injury, and disability.
NIOSH, one of CDC’s Centers, Institute,
and Offices, was established by the
Occupational Safety and Health Act of
1970. NIOSH plans, directs, and
coordinates a national program to
develop and establish recommended
occupational safety and health
standards; conduct research and
training; provide technical assistance;
and perform related activities to assure
safe and healthful working conditions
for every working person in the United
States.
Three NIOSH research facilities—the
Robert A. Taft Campus, Taft North
Campus, and the Alice Hamilton
Laboratory Campus—currently are
located in Cincinnati, Ohio. Even with
multiple renovations through the years,
these facilities no longer meet the needs
of modern research. The facilities’
deficiencies adversely affect NIOSH’s
ability to conduct its important
Cincinnati-based occupational safety
and health research. The facilities’
outdated designs create health and
safety challenges for NIOSH laboratory
employees and administrative staff. It is
not possible to renovate the facilities
located on the three campuses to meet
current standards and requirements.
Additionally, the current distribution of
NIOSH activities across separate
campuses results in inefficiencies in
scientific collaboration and the
duplication of operational support
activities. Therefore, CDC is proposing
to relocate and consolidate its
Cincinnati-based functions and
personnel (approximately 550
employees) currently housed at the
three existing campuses to a new,
consolidated campus in Cincinnati.
Potential locations for the proposed
new campus were identified through a
comprehensive site selection process
conducted by GSA on behalf of CDC. In
June 2016, GSA issued a Request for
Expressions of Interest (REOI) seeking
potential sites capable of
accommodating the proposed new
E:\FR\FM\14JYN1.SGM
14JYN1
mstockstill on DSK30JT082PROD with NOTICES
32554
Federal Register / Vol. 82, No. 134 / Friday, July 14, 2017 / Notices
campus. The REOI specified minimum
and additional functional, geographical,
and environmental criteria that would
be used to evaluate sites for suitability.
In particular, candidate sites were to be
from 10 to 17 acres in size and located
in Cincinnati, within a certain area
(Delineated Area) defined by factors
such as transportation infrastructure,
proximity to other research facilities,
and the residence patterns of current
NIOSH employees.
In response to the REOI, GSA received
seven expressions of interest (i.e.,
Solicited Sites). Following an
assessment of each site based on the
minimum and additional criteria, GSA
found that only one site qualified for
further consideration. During this
screening and assessment process, GSA
identified one additional site (i.e.,
Unsolicited Site) that was added to the
qualifying Solicited Site to create a
larger parcel better capable of
supporting the development of the
proposed campus. The resulting
combined site (i.e., the Site)
encompasses all land between Martin
Luther King Drive East to the south,
Harvey Avenue to the west, Ridgeway
Avenue to the north, and Reading Road
to the east in Cincinnati, Ohio. All other
Solicited Sites were eliminated from
further consideration because they did
not adequately meet the selection
criteria specified in the REOI or, in one
case, were withdrawn from
consideration by the offeror.
In accordance with NEPA, as
implemented by the CEQ regulations (40
CFR parts 1500–1508), CDC is initiating
the preparation of an EIS for the
proposed acquisition of the Site and
construction of a new consolidated
CDC/NIOSH campus on the Site. Under
NEPA, Federal agencies are required to
evaluate the environmental effects of
their proposed actions and a range of
reasonable alternatives to the proposed
action before making a decision. At a
minimum, the EIS will evaluate the
following two alternatives: the Proposed
Action Alternative (acquisition of the
Site and construction of a new
consolidated CDC/NIOSH campus) and
the No Action Alternative (continued
use of the existing campuses for the
foreseeable future).
Scoping Process: In accordance with
NEPA, a public scoping process will be
conducted to establish the range of
issues to be addressed during the
preparation of the EIS. Scoping is an
early and open process for determining
the scope of issues to be addressed and
identifying issues that should be taken
into account in selecting an alternative
for implementation. To that end, during
the scoping process, CDC will actively
VerDate Sep<11>2014
17:44 Jul 13, 2017
Jkt 241001
seek input from interested people,
organizations, Federally-recognized
Native American tribes, and Federal,
state, and regional agencies.
The purpose of this Notice is to
inform interested parties regarding
CDC’s plan to prepare an EIS for the
proposed Site acquisition in Cincinnati,
Ohio and the development of the Site
into a new consolidated HHS/CDC/
NIOSH campus; to provide information
on the nature of the Proposed Action;
and to initiate the scoping process. The
public scoping meeting will be held on
August 1, 2017 at the Walnut Hills High
School, 3250 Victory Parkway,
Cincinnati, Ohio 45207, from 6:00 p.m.
to 9:00 p.m. Eastern Time. Attendees
should use the Parking Lot D entrance.
The public scoping meeting will be in
open house format. General information
on the Site and the Proposed Action
will be provided and representatives of
CDC and GSA will be available to
answer one-on-one questions. There
will be no formal presentation or
question-and-answer session.
Participants may arrive at any time
between 6:00 p.m. and 9:00 p.m. Eastern
Time. Comment forms will be provided
for written comments and a
stenographer will be available to
transcribe oral comments. Through the
NEPA scoping process, CDC will also
facilitate consultation with the public as
required by Section 106 of the NHPA.
comments should address any of the
following: (a) Evaluate whether the
proposed collection of information is
necessary for the proper performance of
the functions of the agency, including
whether the information will have
practical utility; (b) Evaluate the
accuracy of the agencies estimate of the
burden of the proposed collection of
information, including the validity of
the methodology and assumptions used;
(c) Enhance the quality, utility, and
clarity of the information to be
collected; (d) Minimize the burden of
the collection of information on those
who are to respond, including through
the use of appropriate automated,
electronic, mechanical, or other
technological collection techniques or
other forms of information technology,
e.g., permitting electronic submission of
responses; and (e) Assess information
collection costs.
To request additional information on
the proposed project or to obtain a copy
of the information collection plan and
instruments, call (404) 639–7570 or
send an email to omb@cdc.gov. Written
comments and/or suggestions regarding
the items contained in this notice
should be directed to the Attention:
CDC Desk Officer, Office of Management
and Budget, Washington, DC 20503 or
by fax to (202) 395–5806. Written
comments should be received within 30
days of this notice.
Dated: July 6, 2017.
Sandra Cashman,
Executive Secretary, Centers for Disease
Control and Prevention.
Proposed Project
Zika virus persistence in body fluids
of patients with Zika virus infection in
Puerto Rico (ZIPER Study) (OMB
Control Number 0920–1140, Expiration
Date 10/31/2017)—Revision—National
Center for Emerging and Zoonotic
Infectious Diseases (NCEZID), Centers
for Disease Control and Prevention
(CDC).
[FR Doc. 2017–14474 Filed 7–13–17; 8:45 am]
BILLING CODE 4163–18–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Disease Control and
Prevention
[30Day–17–1140]
Agency Forms Undergoing Paperwork
Reduction Act Review
The Centers for Disease Control and
Prevention (CDC) has submitted the
following information collection request
to the Office of Management and Budget
(OMB) for review and approval in
accordance with the Paperwork
Reduction Act of 1995. The notice for
the proposed information collection is
published to obtain comments from the
public and affected agencies.
Written comments and suggestions
from the public and affected agencies
concerning the proposed collection of
information are encouraged. Your
PO 00000
Frm 00027
Fmt 4703
Sfmt 4703
Background and Brief Description
CDC is seeking a one-year OMB
approval to extend the ZIPER Study
information collection.
The Zika Persistence (ZIPER) study
will help inform the presence and
duration of ZIKV shedding in several
body fluids among RT–PCR-positive
ZIKV cases from Puerto Rico. It will also
provide information regarding the
duration of detection of anti-ZIKV IgM
antibodies and the time for development
of IgG antibodies among the same
population. In addition, this study will
determine the prevalence of anti-ZIKV
IgM and IgG, and virus shedding in
body fluids among household contacts
of ZIKV cases.
We propose to investigate the
persistence (shedding) of ZIKV in
different body fluids and its relation to
E:\FR\FM\14JYN1.SGM
14JYN1
]]>Agencies
[Federal Register Volume 82, Number 134 (Friday, July 14, 2017)]
[Notices]
[Pages 32553-32554]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2017-14474]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Centers for Disease Control and Prevention
[Docket No. CDC-2017-0059]
Notice of Intent To Prepare an Environmental Impact Statement,
Public Scoping Meeting, and Request for Comments; Acquisition of Site
for Development as a New Consolidated Campus for the Centers for
Disease Control and Prevention/National Institute for Occupational
Safety and Health (CDC/NIOSH) in Cincinnati, Ohio
AGENCY: Centers for Disease Control and Prevention (CDC), Department of
Health and Human Services (HHS).
ACTION: Notice of intent; announcement of public meeting; and request
for comments.
-----------------------------------------------------------------------
SUMMARY: The Centers for Disease Control and Prevention (CDC) within
the Department of Health and Human Services (HHS), in cooperation with
the General Services Administration (GSA), announces its intent to
prepare an Environmental Impact Statement (EIS) to analyze and assess
the environmental impacts of the proposed acquisition of a site in
Cincinnati, Ohio, and the development of this site into a new
consolidated CDC/National Institute for Occupational Safety and Health
(NIOSH) campus (Proposed Action). The site being considered for
acquisition and development is bounded by Martin Luther King Drive East
to the south, Harvey Avenue to the west, Ridgeway Avenue to the north,
and Reading Road to the east.
This notice is pursuant to the requirements of the National
Environmental Policy Act of 1969 (NEPA) as implemented by the Council
on Environmental Quality (CEQ) Regulations (40 CFR parts 1500-1508).
CDC, in cooperation with GSA, also intends to initiate consultation, as
required by Section 106 of the National Historic Preservation Act
(NHPA), to evaluate the potential effects, if any, of the Proposed
Action on historic properties.
DATES:
Public Scoping Meeting: A public scoping meeting in open house
format will be held on August 1, 2017, in Cincinnati, Ohio. The meeting
will begin at 6:00 p.m. and end no later than 9:00 p.m.
Written comments: Written scoping comments must be submitted by
August 14, 2017.
Deadline for Requests for Special Accommodations: Persons wishing
to participate in the public scoping meeting who need special
accommodations should contact Harry Marsh at 770-488-8170 by 5:00 p.m.
Eastern Time, July 26, 2017.
ADDRESSES: The public scoping meeting will be held at the Walnut Hills
High School, 3250 Victory Parkway, Cincinnati, Ohio 45207. Attendees
should use the Parking Lot D entrance.
You may submit comments identified by Docket No. CDC-2017-0059 by
either of the following methods:
Federal eRulemaking Portal: https://www.regulations.gov
(Follow the instructions for submitting comments).
U.S. Mail: Harry Marsh, Architect, Office of Safety,
Security and Asset Management (OSSAM), Centers for Disease Control and
Prevention, 1600 Clifton Road NE., MS-K80, Atlanta, Georgia 30329-4027.
Instructions: All submissions must include the agency name and
Docket Number. All relevant comments received will be posted to https://www.regulations.gov (personally identifiable information, except for
first and last names, will be redacted). For access to the docket to
review background documents or comments received, go to https://www.regulations.gov.
FOR FURTHER INFORMATION CONTACT: Harry Marsh, Architect, Office of
Safety, Security and Asset Management (OSSAM), Centers for Disease
Control and Prevention, 1600 Clifton Road NE., MS-K80, Atlanta, Georgia
30329-4027, phone: (770) 488-8170, or email: cdc-cincinnati-eis@cdc.gov.
SUPPLEMENTARY INFORMATION:
Background: CDC is dedicated to protecting health and promoting
quality of life through the prevention and control of disease, injury,
and disability. NIOSH, one of CDC's Centers, Institute, and Offices,
was established by the Occupational Safety and Health Act of 1970.
NIOSH plans, directs, and coordinates a national program to develop and
establish recommended occupational safety and health standards; conduct
research and training; provide technical assistance; and perform
related activities to assure safe and healthful working conditions for
every working person in the United States.
Three NIOSH research facilities--the Robert A. Taft Campus, Taft
North Campus, and the Alice Hamilton Laboratory Campus--currently are
located in Cincinnati, Ohio. Even with multiple renovations through the
years, these facilities no longer meet the needs of modern research.
The facilities' deficiencies adversely affect NIOSH's ability to
conduct its important Cincinnati-based occupational safety and health
research. The facilities' outdated designs create health and safety
challenges for NIOSH laboratory employees and administrative staff. It
is not possible to renovate the facilities located on the three
campuses to meet current standards and requirements. Additionally, the
current distribution of NIOSH activities across separate campuses
results in inefficiencies in scientific collaboration and the
duplication of operational support activities. Therefore, CDC is
proposing to relocate and consolidate its Cincinnati-based functions
and personnel (approximately 550 employees) currently housed at the
three existing campuses to a new, consolidated campus in Cincinnati.
Potential locations for the proposed new campus were identified
through a comprehensive site selection process conducted by GSA on
behalf of CDC. In June 2016, GSA issued a Request for Expressions of
Interest (REOI) seeking potential sites capable of accommodating the
proposed new
[[Page 32554]]
campus. The REOI specified minimum and additional functional,
geographical, and environmental criteria that would be used to evaluate
sites for suitability. In particular, candidate sites were to be from
10 to 17 acres in size and located in Cincinnati, within a certain area
(Delineated Area) defined by factors such as transportation
infrastructure, proximity to other research facilities, and the
residence patterns of current NIOSH employees.
In response to the REOI, GSA received seven expressions of interest
(i.e., Solicited Sites). Following an assessment of each site based on
the minimum and additional criteria, GSA found that only one site
qualified for further consideration. During this screening and
assessment process, GSA identified one additional site (i.e.,
Unsolicited Site) that was added to the qualifying Solicited Site to
create a larger parcel better capable of supporting the development of
the proposed campus. The resulting combined site (i.e., the Site)
encompasses all land between Martin Luther King Drive East to the
south, Harvey Avenue to the west, Ridgeway Avenue to the north, and
Reading Road to the east in Cincinnati, Ohio. All other Solicited Sites
were eliminated from further consideration because they did not
adequately meet the selection criteria specified in the REOI or, in one
case, were withdrawn from consideration by the offeror.
In accordance with NEPA, as implemented by the CEQ regulations (40
CFR parts 1500-1508), CDC is initiating the preparation of an EIS for
the proposed acquisition of the Site and construction of a new
consolidated CDC/NIOSH campus on the Site. Under NEPA, Federal agencies
are required to evaluate the environmental effects of their proposed
actions and a range of reasonable alternatives to the proposed action
before making a decision. At a minimum, the EIS will evaluate the
following two alternatives: the Proposed Action Alternative
(acquisition of the Site and construction of a new consolidated CDC/
NIOSH campus) and the No Action Alternative (continued use of the
existing campuses for the foreseeable future).
Scoping Process: In accordance with NEPA, a public scoping process
will be conducted to establish the range of issues to be addressed
during the preparation of the EIS. Scoping is an early and open process
for determining the scope of issues to be addressed and identifying
issues that should be taken into account in selecting an alternative
for implementation. To that end, during the scoping process, CDC will
actively seek input from interested people, organizations, Federally-
recognized Native American tribes, and Federal, state, and regional
agencies.
The purpose of this Notice is to inform interested parties
regarding CDC's plan to prepare an EIS for the proposed Site
acquisition in Cincinnati, Ohio and the development of the Site into a
new consolidated HHS/CDC/NIOSH campus; to provide information on the
nature of the Proposed Action; and to initiate the scoping process. The
public scoping meeting will be held on August 1, 2017 at the Walnut
Hills High School, 3250 Victory Parkway, Cincinnati, Ohio 45207, from
6:00 p.m. to 9:00 p.m. Eastern Time. Attendees should use the Parking
Lot D entrance. The public scoping meeting will be in open house
format. General information on the Site and the Proposed Action will be
provided and representatives of CDC and GSA will be available to answer
one-on-one questions. There will be no formal presentation or question-
and-answer session. Participants may arrive at any time between 6:00
p.m. and 9:00 p.m. Eastern Time. Comment forms will be provided for
written comments and a stenographer will be available to transcribe
oral comments. Through the NEPA scoping process, CDC will also
facilitate consultation with the public as required by Section 106 of
the NHPA.
Dated: July 6, 2017.
Sandra Cashman,
Executive Secretary, Centers for Disease Control and Prevention.
[FR Doc. 2017-14474 Filed 7-13-17; 8:45 am]
BILLING CODE 4163-18-P
